Importer of Controlled Substances Application: Lipomed, 37247-37251 [2024-09802]

Download as PDF 37247 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on December 11, 2023, Entheogen Pharmaceuticals Inc, 17349 Muskrat Avenue, Adelanto, California, 92301 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Drug code Controlled substance Ibogaine ........................................................................................................................................................................... Lysergic Acid Diethylamide ............................................................................................................................................. Marihuana Extract ........................................................................................................................................................... Marihuana ........................................................................................................................................................................ Mescaline ......................................................................................................................................................................... Dimethyltryptamine .......................................................................................................................................................... Psilocybin ......................................................................................................................................................................... Psilocyn ........................................................................................................................................................................... In reference to drug codes 7260 (Ibogaine), 7315 (Lysergic Acid Diethylamide), 7381 (Mescaline), 7435 (Dimethyltryptamine), 7437 (Psilocybin), and 7438 (Psilocyn), the company plans to bulk manufacture the listed controlled substances for internal research and analytical development purposes. No other activities for these drug codes are authorized for this registration. Marsha Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–09789 Filed 5–3–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1358] Importer of Controlled Substances Application: Lipomed Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before June 5, 2024. Such persons may also file a written request for a hearing on the application on or before June 5, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be DATES: ddrumheller on DSK120RN23PROD with NOTICES1 Jkt 262001 PO 00000 Frm 00088 Fmt 4703 In accordance with 21 CFR 1301.34(a), this is notice that on February 7, 2024, Lipomed, 150 Cambridgepark Drive, Suite 705, Cambridge, Massachusetts 02140–2300, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Drug code Sfmt 4703 I I I I I I I I SUPPLEMENTARY INFORMATION: 3-Fluoro-N-methylcathinone (3–FMC) ................................................................................................................................. Cathinone ............................................................................................................................................................................ Methcathinone ..................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ................................................................................................................................. Pentedrone (a-methylaminovalerophenone) ....................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................ 4-Methyl-N-ethylcathinone (4–MEC) ................................................................................................................................... Naphyrone ........................................................................................................................................................................... N-Ethylamphetamine ........................................................................................................................................................... N,N-Dimethylamphetamine .................................................................................................................................................. Fenethylline ......................................................................................................................................................................... Aminorex .............................................................................................................................................................................. 4-Methylaminorex (cis isomer) ............................................................................................................................................ Gamma Hydroxybutyric Acid ............................................................................................................................................... Methaqualone ...................................................................................................................................................................... Mecloqualone ...................................................................................................................................................................... Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine .................................... 18:02 May 03, 2024 7260 7315 7350 7360 7381 7435 7437 7438 aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. Controlled substance VerDate Sep<11>2014 Schedule E:\FR\FM\06MYN1.SGM 06MYN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1585 1590 2010 2565 2572 2780 Schedule I I I I I I I I I I I I I I I I I 37248 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ............................... Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ...................................... Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .............................. Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................... SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .................................................... ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................. 5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone) ................ AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......................... JWH–019 (1-Hexyl-3-(1-naphthoyl) indole) ......................................................................................................................... MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................... FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) AB–PINACA (N-(1-amino-3-methyl- .................................................................................................................................... 1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ...................................................................................................... THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3- ....................................................................................................................... yl](naphthalen-1-yl)methanone) ........................................................................................................................................... 5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .......................... AB–CHMINACA (N-(1-amino-3-methyl-1- ........................................................................................................................... oxobutan-2-yl)-1-(cyclohexylmethyl)- ................................................................................................................................... 1H-indazole-3-carboxamide) ............................................................................................................................................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............ 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .................................................. 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......... ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................... Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) ............................................................... MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate). MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ............ N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) .................................................................................. APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ................................................................ 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ...................................... JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...................................................................................................... 1-(5-Fluoropentyl)-1H-indazole-3-carboxamide ................................................................................................................... 5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ................... 4–CN–CUMYL–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboximide). SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ....................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ......................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .................................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .............................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ........................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .......................................................................................................... NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................. PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..................................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ................................................................................ 4-methyl-alpha-ethylaminopentiophenone (4–MEAP) ......................................................................................................... N-ethylhexedrone ................................................................................................................................................................ Alpha-ethyltryptamine .......................................................................................................................................................... Ibogaine ............................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .................................................................... CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) .............................................. Lysergic acid diethylamide .................................................................................................................................................. 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .................................................................................................. Marihuana extract ................................................................................................................................................................ Marihuana ............................................................................................................................................................................ Tetrahydrocannabinols ........................................................................................................................................................ Parahexyl ............................................................................................................................................................................. Mescaline ............................................................................................................................................................................. 2C–T–2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) .............................................................................................. 3,4,5-Trimethoxyamphetamine ............................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ................................................................................................................................. 4-Bromo-2,5-dimethoxyphenethylamine .............................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ................................................................................................................................. 2,5-Dimethoxyamphetamine ................................................................................................................................................ JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .......................................................................................................... 2,5-Dimethoxy-4-ethylamphetamine .................................................................................................................................... 3,4-Methylenedioxyamphetamine ........................................................................................................................................ 5-Methoxy-3,4-methylenedioxyamphetamine ...................................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine ...................................................................................................................... 3,4-Methylenedioxy-N-ethylamphetamine ........................................................................................................................... 3,4-Methylenedioxymethamphetamine ................................................................................................................................ 4-Methoxyamphetamine ...................................................................................................................................................... VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1 Schedule 2785 2786 2788 2789 6250 7008 7010 7011 7012 7019 7020 7021 7023 I I I I I I I I I I I I I 7024 I 7025 7031 I I 7032 7033 7034 7035 7036 7042 I I I I I I 7044 7047 7048 7049 7081 7083 7085 7089 I I I I I I I I 7104 7118 7122 7144 7173 7200 7201 7203 7221 7222 7225 7245 7246 7249 7260 7297 7298 7315 7348 7350 7360 7370 7374 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 37249 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code 5-Methoxy-N–N-dimethyltryptamine .................................................................................................................................... Alpha-methyltryptamine ....................................................................................................................................................... Bufotenine ............................................................................................................................................................................ Diethyltryptamine ................................................................................................................................................................. Dimethyltryptamine .............................................................................................................................................................. Psilocybin ............................................................................................................................................................................. Psilocyn ............................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ................................................................................................................................. 4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ................................................................................................ N-Ethyl-1-phenylcyclohexylamine ........................................................................................................................................ 1-(1-Phenylcyclohexyl)pyrrolidine ........................................................................................................................................ 1-[1-(2-Thienyl)cyclohexyl]piperidine ................................................................................................................................... 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .................................................................................................................................. N-Ethyl-3-piperidyl benzilate ................................................................................................................................................ N-Methyl-3-piperidyl benzilate ............................................................................................................................................. N-Benzylpiperazine .............................................................................................................................................................. 4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ......................................................................................................... 2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ...................................................................................................... 2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ......................................................................................................... 2C–H (2-(2,5-Dimethoxyphenyl) ethanamine) ..................................................................................................................... 2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ............................................................................................................ 2C–C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ...................................................................................................... 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ........................................................................................................ 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ................................................................................................. 2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ........................................................................................ MDPV (3,4-Methylenedioxypyrovalerone) ........................................................................................................................... 25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................ 25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ........................................................ 25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................. Methylone (3,4-Methylenedioxy-N-methylcathinone) .......................................................................................................... Butylone ............................................................................................................................................................................... Pentylone ............................................................................................................................................................................. N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ........................................................ a-PHP, alpha-Pyrrolidinohexanophenone ........................................................................................................................... a-PVP (alpha-pyrrolidinopentiophenone) ............................................................................................................................ a-PBP (alpha-pyrrolidinobutiophenone) .............................................................................................................................. PV8, alpha-Pyrrolidinoheptaphenone .................................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ....................................................................................................... Norfentanyl .......................................................................................................................................................................... Acetyldihydrocodeine ........................................................................................................................................................... Benzylmorphine ................................................................................................................................................................... Codeine-N-oxide .................................................................................................................................................................. Cyprenorphine ..................................................................................................................................................................... Desomorphine ..................................................................................................................................................................... Etorphine (except HCl) ........................................................................................................................................................ Codeine methylbromide ....................................................................................................................................................... Dihydromorphine ................................................................................................................................................................. Difenoxin .............................................................................................................................................................................. Heroin .................................................................................................................................................................................. Hydromorphinol ................................................................................................................................................................... Methyldesorphine ................................................................................................................................................................ Methyldihydromorphine ....................................................................................................................................................... Morphine methylbromide ..................................................................................................................................................... Morphine methylsulfonate ................................................................................................................................................... Morphine-N-oxide ................................................................................................................................................................ Myrophine ............................................................................................................................................................................ Nicocodeine ......................................................................................................................................................................... Nicomorphine ....................................................................................................................................................................... Normorphine ........................................................................................................................................................................ Pholcodine ........................................................................................................................................................................... Thebacon ............................................................................................................................................................................. Acetorphine .......................................................................................................................................................................... Drotebanol ........................................................................................................................................................................... U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .................................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ...................................................................... MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ...................................................................................................... Acetylmethadol .................................................................................................................................................................... Allylprodine .......................................................................................................................................................................... Alphacetylmethadol except levo-alphacetylmethadol .......................................................................................................... Alphameprodine ................................................................................................................................................................... Alphamethadol ..................................................................................................................................................................... Benzethidine ........................................................................................................................................................................ Betacetylmethadol ............................................................................................................................................................... Betameprodine .................................................................................................................................................................... VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1 7431 7432 7433 7434 7435 7437 7438 7439 7443 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7548 7694 8366 9051 9052 9053 9054 9055 9056 9070 9145 9168 9200 9301 9302 9304 9305 9306 9307 9308 9309 9312 9313 9314 9315 9319 9335 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9608 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 37250 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code Betamethadol ....................................................................................................................................................................... Betaprodine ......................................................................................................................................................................... Clonitazene .......................................................................................................................................................................... Dextromoramide .................................................................................................................................................................. Diampromide ....................................................................................................................................................................... Diethylthiambutene .............................................................................................................................................................. Dimenoxadol ........................................................................................................................................................................ Dimepheptanol ..................................................................................................................................................................... Dimethylthiambutene ........................................................................................................................................................... Dioxaphetyl butyrate ............................................................................................................................................................ Dipipanone ........................................................................................................................................................................... Ethylmethylthiambutene ...................................................................................................................................................... Etonitazene .......................................................................................................................................................................... Etoxeridine ........................................................................................................................................................................... Furethidine ........................................................................................................................................................................... Hydroxypethidine ................................................................................................................................................................. Ketobemidone ...................................................................................................................................................................... Levomoramide ..................................................................................................................................................................... Levophenacylmorphan ........................................................................................................................................................ Morpheridine ........................................................................................................................................................................ Noracymethadol ................................................................................................................................................................... Norlevorphanol .................................................................................................................................................................... Normethadone ..................................................................................................................................................................... Norpipanone ........................................................................................................................................................................ Phenadoxone ....................................................................................................................................................................... Phenampromide .................................................................................................................................................................. Phenoperidine ...................................................................................................................................................................... Piritramide ............................................................................................................................................................................ Proheptazine ........................................................................................................................................................................ Properidine .......................................................................................................................................................................... Racemoramide .................................................................................................................................................................... Trimeperidine ....................................................................................................................................................................... Phenomorphan .................................................................................................................................................................... Propiram .............................................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine .......................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .................................................................................................................. Tilidine ................................................................................................................................................................................. Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ..................................................................................... Para-Fluorofentanyl ............................................................................................................................................................. 3-Methylfentanyl .................................................................................................................................................................. Alpha-Methylfentanyl ........................................................................................................................................................... Acetyl-alpha-methylfentanyl ................................................................................................................................................. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ........................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ................................................................................... Butyryl Fentanyl ................................................................................................................................................................... Para-fluorobutyryl fentanyl ................................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ............................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ............................................................................................. Para-chloroisobutyryl fentanyl ............................................................................................................................................. Isobutyryl fentanyl ................................................................................................................................................................ Beta-hydroxyfentanyl ........................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ............................................................................................................................................ Alpha-methylthiofentanyl ..................................................................................................................................................... 3-Methylthiofentanyl ............................................................................................................................................................. Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ................................................................. Thiofentanyl ......................................................................................................................................................................... Beta-hydroxythiofentanyl ..................................................................................................................................................... Para-methoxybutyryl fentanyl .............................................................................................................................................. Ocfentanil ............................................................................................................................................................................. Valeryl fentanyl .................................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ............................................................................. Cyclopropyl Fentanyl ........................................................................................................................................................... Cyclopentyl fentanyl ............................................................................................................................................................ Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ......................................................................................... Amphetamine ....................................................................................................................................................................... Methamphetamine ............................................................................................................................................................... Lisdexamfetamine ................................................................................................................................................................ Phenmetrazine ..................................................................................................................................................................... Methylphenidate .................................................................................................................................................................. Amobarbital .......................................................................................................................................................................... Pentobarbital ........................................................................................................................................................................ Secobarbital ......................................................................................................................................................................... Glutethimide ......................................................................................................................................................................... Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration (FDA). VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1 9609 9611 9612 9613 9615 9616 9617 9618 9619 9621 9622 9623 9624 9625 9626 9627 9628 9629 9631 9632 9633 9634 9635 9636 9637 9638 9641 9642 9643 9644 9645 9646 9647 9649 9661 9663 9750 9811 9812 9813 9814 9815 9816 9821 9822 9823 9824 9825 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9845 9847 9850 1100 1105 1205 1631 1724 2125 2270 2315 2550 7365 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II 37251 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices Controlled substance Drug code ddrumheller on DSK120RN23PROD with NOTICES1 Nabilone ............................................................................................................................................................................... 1-Phenylcyclohexylamine .................................................................................................................................................... Phencyclidine ....................................................................................................................................................................... ANPP (4-Anilino-N-phenethyl-4-piperidine) ......................................................................................................................... Phenylacetone ..................................................................................................................................................................... 1-Piperidinocyclohexanecarbonitrile .................................................................................................................................... Alphaprodine ........................................................................................................................................................................ Anileridine ............................................................................................................................................................................ Cocaine ................................................................................................................................................................................ Codeine ............................................................................................................................................................................... Etorphine HCl ...................................................................................................................................................................... Dihydrocodeine .................................................................................................................................................................... Oxycodone ........................................................................................................................................................................... Hydromorphone ................................................................................................................................................................... Diphenoxylate ...................................................................................................................................................................... Ecgonine .............................................................................................................................................................................. Ethylmorphine ...................................................................................................................................................................... Hydrocodone ....................................................................................................................................................................... Levomethorphan .................................................................................................................................................................. Levorphanol ......................................................................................................................................................................... Isomethadone ...................................................................................................................................................................... Meperidine ........................................................................................................................................................................... Meperidine-intermediate-A .................................................................................................................................................. Meperidine intermediate-B .................................................................................................................................................. Meperidine intermediate-C .................................................................................................................................................. Metazocine .......................................................................................................................................................................... Methadone ........................................................................................................................................................................... Methadone intermediate ...................................................................................................................................................... Metopon ............................................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................. Morphine .............................................................................................................................................................................. Oripavine ............................................................................................................................................................................. Thebaine .............................................................................................................................................................................. Dihydroetorphine ................................................................................................................................................................. Levo-alphacetylmethadol ..................................................................................................................................................... Oxymorphone ...................................................................................................................................................................... Noroxymorphone ................................................................................................................................................................. Phenazocine ........................................................................................................................................................................ Thiafentanil .......................................................................................................................................................................... Piminodine ........................................................................................................................................................................... Racemethorphan ................................................................................................................................................................. Racemorphan ...................................................................................................................................................................... Alfentanil .............................................................................................................................................................................. Remifentanil ......................................................................................................................................................................... Sufentanil ............................................................................................................................................................................. Carfentanil ........................................................................................................................................................................... Tapentadol ........................................................................................................................................................................... Bezitramide .......................................................................................................................................................................... Fentanyl ............................................................................................................................................................................... Moramide-intermediate ........................................................................................................................................................ The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non- VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 approved finished dosage forms for commercial sale. Marsha Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–09802 Filed 5–3–24; 8:45 am] BILLING CODE P PO 00000 7379 7460 7471 8333 8501 8603 9010 9020 9041 9050 9059 9120 9143 9150 9170 9180 9190 9193 9210 9220 9226 9230 9232 9233 9234 9240 9250 9254 9260 9273 9300 9330 9333 9334 9648 9652 9668 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 Schedule II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II II DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1349] Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. SUMMARY: Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

[Federal Register Volume 89, Number 88 (Monday, May 6, 2024)]
[Notices]
[Pages 37247-37251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09802]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1358]


Importer of Controlled Substances Application: Lipomed

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Lipomed has applied to be registered as an importer of basic 
class(es) of controlled substance(s). Refer to SUPPLEMENTARY 
INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
June 5, 2024. Such persons may also file a written request for a 
hearing on the application on or before June 5, 2024.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 7, 2024, Lipomed, 150 Cambridgepark Drive, 
Suite 705, Cambridge, Massachusetts 02140-2300, applied to be 
registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
            Controlled substance              Drug code      Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).........         1233  I
Cathinone..................................         1235  I
Methcathinone..............................         1237  I
4-Fluoro-N-methylcathinone (4-FMC).........         1238  I
Pentedrone ([alpha]-                                1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)....         1248  I
4-Methyl-N-ethylcathinone (4-MEC)..........         1249  I
Naphyrone..................................         1258  I
N-Ethylamphetamine.........................         1475  I
N,N-Dimethylamphetamine....................         1480  I
Fenethylline...............................         1503  I
Aminorex...................................         1585  I
4-Methylaminorex (cis isomer)..............         1590  I
Gamma Hydroxybutyric Acid..................         2010  I
Methaqualone...............................         2565  I
Mecloqualone...............................         2572  I
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-             2780  I
 methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.

[[Page 37248]]

 
Flualprazolam (8-chloro-6-(2-fluorophenyl)-         2785  I
 1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-          2786  I
 nitro-4H-benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-        2788  I
 methyl-4H-benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2-              2789  I
 chlorophenyl)-1- methyl-1,3-dihydro-2H-
 benzo[e][1,4]diazepin-2-one.
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)         6250  I
 indole).
SR-18 (Also known as RCS-8) (1-                     7008  I
 Cyclohexylethyl-3-(2-methoxyphenylacetyl)
 indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-            7010  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-            7011  I
 pentyl)1H-indol-3-yl] (2,2,3,3-
 tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-        7012  I
 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
 carboxamide).
JWH-019 (1-Hexyl-3-(1-naphthoyl) indole)...         7019  I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-        7020  I
 1H-indazole-3-carboxamido)-3,3-
 dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-          7021  I
 (4-fluorobenzyl)-1Hindazole-3-carboxamido)-
 3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-............         7023  I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-
 carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-         7024  I
yl](naphthalen-1-yl)methanone).............
5F-AB-PINACA (N-(1-amino-3methyl-1-oxobutan-        7025  I
 2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
 carboxamide).
AB-CHMINACA (N-(1-amino-3-methyl-1-........         7031  I
oxobutan-2-yl)-1-(cyclohexylmethyl)-.......
1H-indazole-3-carboxamide).................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-             7032  I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-            7033  I
 indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-             7034  I
 fluoropentyl)-1H-indazole-3-carboxamido)-
 3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-              7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide).
Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-          7036  I
 carboxamido) 3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-             7042  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-                7044  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3-methylbutanoate).
N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-           7047  I
 indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-        7048  I
 1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-         7049  I
 (5-fluoropentyl)-1H-indazole-3-
 carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)         7081  I
 indole).
1-(5-Fluoropentyl)-1H-indazole-3-                   7083  I
 carboxamide.
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-           7085  I
 phenylpropan-2-yl)-1H-pyrrolo[2,3-
 b]pyridine-3-carboxamide).
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-                 7089  I
 BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-
 BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-
 phenylpropan-2-yl)-1H-indazole-3-
 carboximide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-        7104  I
 methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-          7118  I
 (1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)          7122  I
 indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-            7144  I
 tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)....         7173  I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-           7200  I
 naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)          7201  I
 indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)          7203  I
 indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-              7221  I
 fluoropentyl)-1H-indole-3-carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-          7222  I
 carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-         7225  I
 1H-indole-3-carboxylate).
4-methyl-alpha-ethylaminopentiophenone (4-          7245  I
 MEAP).
N-ethylhexedrone...........................         7246  I
Alpha-ethyltryptamine......................         7249  I
Ibogaine...................................         7260  I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-                7297  I
 [(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1-                     7298  I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................         7315  I
2,5-Dimethoxy-4-(n)-                                7348  I
 propylthiophenethylamine (2C-T-7).
Marihuana extract..........................         7350  I
Marihuana..................................         7360  I
Tetrahydrocannabinols......................         7370  I
Parahexyl..................................         7374  I
Mescaline..................................         7381  I
2C-T-2, (2-(4-Ethylthio-2,5-                        7385  I
 dimethoxyphenyl) ethanamine).
3,4,5-Trimethoxyamphetamine................         7390  I
4-Bromo-2,5-dimethoxyamphetamine...........         7391  I
4-Bromo-2,5-dimethoxyphenethylamine........         7392  I
4-Methyl-2,5-dimethoxyamphetamine..........         7395  I
2,5-Dimethoxyamphetamine...................         7396  I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)          7398  I
 indole).
2,5-Dimethoxy-4-ethylamphetamine...........         7399  I
3,4-Methylenedioxyamphetamine..............         7400  I
5-Methoxy-3,4-methylenedioxyamphetamine....         7401  I
N-Hydroxy-3,4-methylenedioxyamphetamine....         7402  I
3,4-Methylenedioxy-N-ethylamphetamine......         7404  I
3,4-Methylenedioxymethamphetamine..........         7405  I
4-Methoxyamphetamine.......................         7411  I

[[Page 37249]]

 
5-Methoxy-N-N-dimethyltryptamine...........         7431  I
Alpha-methyltryptamine.....................         7432  I
Bufotenine.................................         7433  I
Diethyltryptamine..........................         7434  I
Dimethyltryptamine.........................         7435  I
Psilocybin.................................         7437  I
Psilocyn...................................         7438  I
5-Methoxy-N,N-diisopropyltryptamine........         7439  I
4-chloro-alpha-pyrrolidinovalerophenone (4-         7443  I
 chloro-a-PVP).
N-Ethyl-1-phenylcyclohexylamine............         7455  I
1-(1-Phenylcyclohexyl)pyrrolidine..........         7458  I
1-[1-(2-Thienyl)cyclohexyl]piperidine......         7470  I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine.....         7473  I
N-Ethyl-3-piperidyl benzilate..............         7482  I
N-Methyl-3-piperidyl benzilate.............         7484  I
N-Benzylpiperazine.........................         7493  I
4-MePPP (4-Methyl-                                  7498  I
 alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl)              7508  I
 ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)               7509  I
 ethanamine).
2C-H (2-(2,5-Dimethoxyphenyl) ethanamine)..         7517  I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl)                7518  I
 ethanamine).
2C-C (2-(4-Chloro-2,5-dimethoxyphenyl)              7519  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl)              7521  I
 ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl)          7524  I
 ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5-                    7532  I
 dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)......         7535  I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-         7536  I
 N-(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-        7537  I
 N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-        7538  I
 (2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N-                    7540  I
 methylcathinone).
Butylone...................................         7541  I
Pentylone..................................         7542  I
N-Ethylpentylone, ephylone (1-(1,3-                 7543  I
 benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
 one).
[alpha]-PHP, alpha-Pyrrolidinohexanophenone         7544  I
[alpha]-PVP (alpha-                                 7545  I
 pyrrolidinopentiophenone).
[alpha]-PBP (alpha-pyrrolidinobutiophenone)         7546  I
PV8, alpha-Pyrrolidinoheptaphenone.........         7548  I
AM-694 (1-(5-Fluoropentyl)-3-(2-                    7694  I
 iodobenzoyl) indole).
Norfentanyl................................         8366  I
Acetyldihydrocodeine.......................         9051  I
Benzylmorphine.............................         9052  I
Codeine-N-oxide............................         9053  I
Cyprenorphine..............................         9054  I
Desomorphine...............................         9055  I
Etorphine (except HCl).....................         9056  I
Codeine methylbromide......................         9070  I
Dihydromorphine............................         9145  I
Difenoxin..................................         9168  I
Heroin.....................................         9200  I
Hydromorphinol.............................         9301  I
Methyldesorphine...........................         9302  I
Methyldihydromorphine......................         9304  I
Morphine methylbromide.....................         9305  I
Morphine methylsulfonate...................         9306  I
Morphine-N-oxide...........................         9307  I
Myrophine..................................         9308  I
Nicocodeine................................         9309  I
Nicomorphine...............................         9312  I
Normorphine................................         9313  I
Pholcodine.................................         9314  I
Thebacon...................................         9315  I
Acetorphine................................         9319  I
Drotebanol.................................         9335  I
U-47700 (3,4-dichloro-N-[2-                         9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                        9551  I
 dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2-                         9560  I
 diphenylethyl)piperazine)).
Acetylmethadol.............................         9601  I
Allylprodine...............................         9602  I
Alphacetylmethadol except levo-                     9603  I
 alphacetylmethadol.
Alphameprodine.............................         9604  I
Alphamethadol..............................         9605  I
Benzethidine...............................         9606  I
Betacetylmethadol..........................         9607  I
Betameprodine..............................         9608  I

[[Page 37250]]

 
Betamethadol...............................         9609  I
Betaprodine................................         9611  I
Clonitazene................................         9612  I
Dextromoramide.............................         9613  I
Diampromide................................         9615  I
Diethylthiambutene.........................         9616  I
Dimenoxadol................................         9617  I
Dimepheptanol..............................         9618  I
Dimethylthiambutene........................         9619  I
Dioxaphetyl butyrate.......................         9621  I
Dipipanone.................................         9622  I
Ethylmethylthiambutene.....................         9623  I
Etonitazene................................         9624  I
Etoxeridine................................         9625  I
Furethidine................................         9626  I
Hydroxypethidine...........................         9627  I
Ketobemidone...............................         9628  I
Levomoramide...............................         9629  I
Levophenacylmorphan........................         9631  I
Morpheridine...............................         9632  I
Noracymethadol.............................         9633  I
Norlevorphanol.............................         9634  I
Normethadone...............................         9635  I
Norpipanone................................         9636  I
Phenadoxone................................         9637  I
Phenampromide..............................         9638  I
Phenoperidine..............................         9641  I
Piritramide................................         9642  I
Proheptazine...............................         9643  I
Properidine................................         9644  I
Racemoramide...............................         9645  I
Trimeperidine..............................         9646  I
Phenomorphan...............................         9647  I
Propiram...................................         9649  I
1-Methyl-4-phenyl-4-propionoxypiperidine...         9661  I
1-(2-Phenylethyl)-4-phenyl-4-                       9663  I
 acetoxypiperidine.
Tilidine...................................         9750  I
Acryl fentanyl (N-(1-phenethylpiperidin-4-          9811  I
 yl)-N-phenylacrylamide).
Para-Fluorofentanyl........................         9812  I
3-Methylfentanyl...........................         9813  I
Alpha-Methylfentanyl.......................         9814  I
Acetyl-alpha-methylfentanyl................         9815  I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-         9816  I
 4-yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-         9821  I
 yl)-N-phenylacetamide).
Butyryl Fentanyl...........................         9822  I
Para-fluorobutyryl fentanyl................         9823  I
4-Fluoroisobutyryl fentanyl (N-(4-                  9824  I
 fluorophenyl)-N-(1-phenethylpiperidin-4-
 yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-          9825  I
 phenylacetamide.
Para-chloroisobutyryl fentanyl.............         9826  I
Isobutyryl fentanyl........................         9827  I
Beta-hydroxyfentanyl.......................         9830  I
Beta-hydroxy-3-methylfentanyl..............         9831  I
Alpha-methylthiofentanyl...................         9832  I
3-Methylthiofentanyl.......................         9833  I
Furanyl fentanyl (N-(1-phenethylpiperidin-4-        9834  I
 yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl...............................         9835  I
Beta-hydroxythiofentanyl...................         9836  I
Para-methoxybutyryl fentanyl...............         9837  I
Ocfentanil.................................         9838  I
Valeryl fentanyl...........................         9840  I
N-(1-phenethylpiperidin-4-yl)-N-                    9843  I
 phenyltetrahydrofuran-2-carboxamide).
Cyclopropyl Fentanyl.......................         9845  I
Cyclopentyl fentanyl.......................         9847  I
Fentanyl related-compounds as defined in 21         9850  I
 CFR 1308.11(h).
Amphetamine................................         1100  II
Methamphetamine............................         1105  II
Lisdexamfetamine...........................         1205  II
Phenmetrazine..............................         1631  II
Methylphenidate............................         1724  II
Amobarbital................................         2125  II
Pentobarbital..............................         2270  II
Secobarbital...............................         2315  II
Glutethimide...............................         2550  II
Dronabinol in an oral solution in a drug            7365  II
 product approved for marketing by the U.S.
 Food and Drug Administration (FDA).

[[Page 37251]]

 
Nabilone...................................         7379  II
1-Phenylcyclohexylamine....................         7460  II
Phencyclidine..............................         7471  II
ANPP (4-Anilino-N-phenethyl-4-piperidine)..         8333  II
Phenylacetone..............................         8501  II
1-Piperidinocyclohexanecarbonitrile........         8603  II
Alphaprodine...............................         9010  II
Anileridine................................         9020  II
Cocaine....................................         9041  II
Codeine....................................         9050  II
Etorphine HCl..............................         9059  II
Dihydrocodeine.............................         9120  II
Oxycodone..................................         9143  II
Hydromorphone..............................         9150  II
Diphenoxylate..............................         9170  II
Ecgonine...................................         9180  II
Ethylmorphine..............................         9190  II
Hydrocodone................................         9193  II
Levomethorphan.............................         9210  II
Levorphanol................................         9220  II
Isomethadone...............................         9226  II
Meperidine.................................         9230  II
Meperidine-intermediate-A..................         9232  II
Meperidine intermediate-B..................         9233  II
Meperidine intermediate-C..................         9234  II
Metazocine.................................         9240  II
Methadone..................................         9250  II
Methadone intermediate.....................         9254  II
Metopon....................................         9260  II
Dextropropoxyphene, bulk (non-dosage forms)         9273  II
Morphine...................................         9300  II
Oripavine..................................         9330  II
Thebaine...................................         9333  II
Dihydroetorphine...........................         9334  II
Levo-alphacetylmethadol....................         9648  II
Oxymorphone................................         9652  II
Noroxymorphone.............................         9668  II
Phenazocine................................         9715  II
Thiafentanil...............................         9729  II
Piminodine.................................         9730  II
Racemethorphan.............................         9732  II
Racemorphan................................         9733  II
Alfentanil.................................         9737  II
Remifentanil...............................         9739  II
Sufentanil.................................         9740  II
Carfentanil................................         9743  II
Tapentadol.................................         9780  II
Bezitramide................................         9800  II
Fentanyl...................................         9801  II
Moramide-intermediate......................         9802  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytics purposes. 
Placement of these drug codes onto the company's registration does not 
translate into automatic approval of subsequent permit applications to 
import controlled substances. No other activities for these drug codes 
are authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-09802 Filed 5-3-24; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.